Cite
Molecular subtyping and functional validation of TTK, TPX2, UBE2C, and LRP8 in sensitivity of TNBC to paclitaxel
MLA
Ramesh Elango, et al. “Molecular Subtyping and Functional Validation of TTK, TPX2, UBE2C, and LRP8 in Sensitivity of TNBC to Paclitaxel.” Molecular Therapy: Methods & Clinical Development, vol. 20, no. 601–614, Mar. 2021, pp. 601–14. EBSCOhost, https://doi.org/10.1016/j.omtm.2021.01.013.
APA
Ramesh Elango, Radhakrishnan Vishnubalaji, Hibah Shaath, & Nehad M. Alajez. (2021). Molecular subtyping and functional validation of TTK, TPX2, UBE2C, and LRP8 in sensitivity of TNBC to paclitaxel. Molecular Therapy: Methods & Clinical Development, 20(601–614), 601–614. https://doi.org/10.1016/j.omtm.2021.01.013
Chicago
Ramesh Elango, Radhakrishnan Vishnubalaji, Hibah Shaath, and Nehad M. Alajez. 2021. “Molecular Subtyping and Functional Validation of TTK, TPX2, UBE2C, and LRP8 in Sensitivity of TNBC to Paclitaxel.” Molecular Therapy: Methods & Clinical Development 20 (601–614): 601–14. doi:10.1016/j.omtm.2021.01.013.